Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Expressing Creativity – the Felix Schoeller Group presents new products at FESPA 2019

The Felix Schoeller Group, Osnabrück-based manufacturer of high-quality specialty papers, is once again this year taking the opportunity offered by FESPA to present and discuss some exciting new products. This year’s slogan – Expressing Creativity – highlights the numerous creative applications for Felix Schoeller products which visitors will have the opportunity to experience at the company’s stand.S-RACE Photo Panel Pro 120 – a product from the S-RACE Dye sublimation papers segment  A jointly developed product is the outcome of the close business relationship between the Felix

Bulletin from Annual General Meeting in InDex Pharmaceuticals Holding AB (publ)

May 6, 2019 – The Annual General Meeting in InDex Pharmaceuticals Holding AB (publ) took place on Monday, May 6, 2019 in the company´s premises at Tomtebodavägen 23a in Stockholm, Sweden.The complete bulletin from the Annual General Meeting (in the Swedish language) is available on the company’s website, www.indexpharma.com. For more information:Peter Zerhouni, CEOPhone: +46 8 508 847 35E-mail: peter.zerhouni@indexpharma.com  PublicationThe information was submitted for publication through the agency of the contact person set out above at 19:00 CET on May 6, 2019. InDex

Decisions at the Annual General Meeting of Securitas AB (publ) 2019

At today's Annual General Meeting of Securitas AB (publ) the following was resolved:The Annual General Meeting adopted the Statement of Income and the Balance Sheet as per December 31, 2018. The Annual General Meeting discharged the Board of Directors and the President from liability for the financial year of 2018. DividendIn accordance with the proposal of the Board, the Meeting resolved to declare a dividend of SEK 4.40 per share. May 8, 2019 was determined as record date for dividend and payment from Euroclear Sweden AB is expected to commence on May 13, 2019. Authorization of

Endomines’ Annual General Meeting postponed – new date is 10 June 2019

Endomines AB, Stock Exchange Release 6 May 2019 at 18:30 CEST The shareholders in Endomines AB (publ) are hereby notified that the planned Annual General Meeting to be held on 3 June 2019 is postponed giving the Board more time to prepare their proposals to the Annual General Meeting. The new date for the Annual General Meeting will be Monday 10 June 2019. For further information, please contact:Marcus Ahlström, Interim CEO, +358 50 544 68 14, Marcus.ahlstrom(at)endomines.com The information was submitted for publication, through the agency of the contact persons set out above,

Ossur Hf : Transactions in relation to share buyback program

Announcement no. 29/2019 6 May 2019  Transactions in relation to share buyback program On 9 October 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2018. The purpose of the share buyback program is to reduce the Company's share capital and adjust the capital structure by distributing capital to shareholders in line with the Company's Capital Structure and Dividend Policy. The program will end no later than 30 June 2019. The Company may purchase up to 5,000,000 shares under the program, corresponding to 1.2% of the current share capital. The

Nexam Chemical presents the first quarter for 2019 on May 7 at 11:00 CET

Nexam Chemical will publish the interim report for the first quarter 2019 on May 7th, 2019 at 08:00 CET. The report  and the presentation  will be available at the company website.In connection with the release - analysts, investors and media are hereby invited to a telephone conference and audio webcast at 11:00 CET where Johan Arvidsson, CEO will present and comment the report. The presentation will be held in Swedish via a conference call or audio webcast at https://

Proposal of board members and remuneration for the annual general meeting in Haldex

Proposal for election of the board of directors and the auditor and resolution on fees for the directors and the auditor (items 10 – 13 on the agenda) Kite Lake Capital Management (UK) LLP, which manages several funds that together are the third largest shareholder in Haldex, proposes the following. Considering that the two largest shareholders, ZF, through its announced acquisition of Wabco, and Knorr Bremse, are the main competitors of Haldex, Kite Lake Capital Management (UK) LLP is making the proposal without consultation with ZF and Knorr Bremse. · the board of directors shall

Annual General Meeting 2019

Stockholm – Tele2 AB (“Tele2”) (Nasdaq Stockholm: TEL2 A and TEL2 B) today announced that the company's Annual General Meeting (AGM) held today voted to support all of the resolutions that the Board of Directors and Nomination Committee proposed to the AGM.The AGM re-elected Andrew Barron, Anders Björkman, Georgi Ganev, Cynthia Gordon, Eva Lindqvist, Lars-Åke Norling and Carla Smits-Nusteling as directors of the Board, and elected Carla Smits-Nusteling as new Chairman of the Board. The AGM re-elected Deloitte as auditor until the end of the 2020 AGM. Pontus Pålsson will continue as

Invitation to Eastnine’s annual seminar

Eastnine welcomes shareholders, representatives from the financial markets and media to our annual seminar in conjunction with the Annual General Meeting. This year, the seminar will be held at Näringslivets Hus, Storgatan 19 in Stockholm, Wednesday 15 May at 13.00-14.30 CET. The Annual General Meeting for shareholders in Eastnine will commence at 15.00 CET. The seminar is open for all. The purpose of the seminar is to present the Company’s development over the last year and our strategic plans, an outlook on the Baltic office property market, and the Company’s ongoing sustainability

Exercise of employee share options in Atea ASA ("the Company")

1. Employees in the Atea Group have exercised 306,251 options.Following the share option exercise the Board of Directors, pursuant to authorisation granted by the Company's Annual General Meeting, has decided to increase the Company's share capital by NOK 306,251 by issuing 306,251 new shares, of par value NOK 1. Following the increase, the Company's share capital is NOK 109,420,389 divided into 109,420,389 shares. The weighted average option exercise price is NOK 52.36. 2. Options exercised by primary insiders 6 May 2019:August Baumann has exercised 70,000 options in the Company,

Share buy-back by Zalaris ASA

On 6 May 2019, Zalaris ASA purchased 1772 own shares on the Oslo Stock Exchange at an average price of NOK 25,4923. Following the purchase Zalaris ASA holds 248.388 own shares, representing ~1,23% of the total outstanding shares. The shares were purchased in accordance with the share buy-back programme announced 12 March 2019, available at www.newsweb.no. This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

#19-891 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details see attached file. For further information concerning this NGM notice please contact: Listing on +46 8 566 390 20 or at listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

Invitation to presentation of ÅF Pöyry’s interim report January-March 2019

ÅF Pöyry invites investors, analysts and media to an online presentation of the interim report for January - March 2019 on May 15 at 14.00 CEST with Jonas Gustavsson, CEO and Stefan Johansson, CFO.The presentation will be held in English. The webcast link and presentation will be available at www.afconsult.com/en/investor-relations/financial-reports. To participate in the conference call, please dial: Sweden: +46 (0)850692180USA: +16315107495UK: +44 (0)2071 928000 Confirmation code: 5997264 ÅF Pöyry's interim report for January - March 2019 will be published on May 15 at 11.

Methenamine hippurate EQL Pharma approved

The pharmaceutical Methenamine hippurate EQL Pharma, tablet 1g, has been approved for sale by the Medicine Products Agencies in Sweden, Denmark and the United Kingdom. In the UK, the product will be licensed to a local partner, Advanz Pharma Corp.Methenamine hippurate EQL Pharma is a pharmaceutical that is taken as a prophylaxis against recurrent urinary tract infections. Methenamine hippurate EQL Pharma contains methenamine, a substance that has been registered in Sweden since 1973. Methenamine hippurate EQL Pharma becomes the first and only generic available on the markets where it is

Heimstaden publishes pro forma financial statement and prospectus as well as appliesfor admission to trading of hybrid capital securities

Publication of pro forma financial statement  On 1 April 2019, Heimstaden AB (publ) (”Heimstaden” or the ”Company”) announced through a press release preliminary pro forma financial information in order to describe its financial position before and after certain larger transactions which have been completed so far during 2019. The Company hereby publishes the final pro forma financial statements which have been reviewed by the Company’s auditor Ernst & Young. The information presented in the pro forma financial statement does not differ from the information provided in the preliminary

Kevin Crough appointed to lead Centiro’s continued North America expansion

BORÅS, May 6 – Centiro, a leading innovator in cloud-based delivery management and supply chain networking solutions, has appointed Kevin Crough to SVP North America, to help retailers, brands, manufacturers, and logistics providers connect their supply chain and distribution networks in the cloud to drive innovation, improve visibility and business performance in the field of e-commerce, omnichannel, and final-mile. “It’s a very exciting time to turn up intensity and focus in North America, and a pleasure to welcome Kevin onboard to lead that effort, building on our North America

ChromoGenics & Ångström Laboratory is presenting new glass knowledge for energy efficiency buildings on Society of Vacuum Coaters.

Professor Claes G. Granqvist (Ångström Laboratory, Uppsala University) presented a new and better way to set performance of façade glass. This was taken place at Society of Vacuum Coaters’ TechCon 2019 in Long Beach, USA.Today’s standards to decide performance of façade glass is based on measurements and calculations for solar angle of incidence of 90°. This technique is used even if the sun almost never hits the glass with that angle. The presentation demonstrates that the sun angle has an angle that it clearly affects the properties of the façade glass. By this ChromoGenics and Ångström

Highlights from the McKinsey Brazil Digital Report

  The Brazilian economy is growing again, with Real GDP growth projected at 2.5% in 2019 and 2.7% in 2020. Interest and inflation rates, as well as country risk have created a favorable investment environment.  More than 2/3 of Brazilians have smartphones and spend on average 9 hours connected to the Internet each day (vs. 6 hours in the US), one of the highest in the world. Brazil has some of the most avid digital consumers globally. By number of users, Brazil ranks globally #2 for WhatsApp, #2 for Instagram, #

Change in number of shares in BrainCool AB (publ), long term investor group acquires all converted shares from L1 Capital

Conversion of convertible notes into shares, as part of the financing agreements announced 5 November, 2018, and 22 January, 2019.The number of convertible notes converted on May 6, 2019, was 48. The number of convertible notes remaining under the third tranche for future conversion is 0. The number of convertible notes remaining under the fourth tranche is 45. The number of shares and the number of votes before the conversion was 38 526 803. Through this conversion, and once the shares from the conversion will be registered at Bolagsverket, the number of shares and the number of votes

GLASTON REVIEWS ITS STRATEGY AND UPDATES FINANCIAL TARGETS AS A RESULT OF ITS ACQUISITION OF BYSTRONIC GLASS

Glaston Corporation           INSIDE INFORMATION        6 May 2019   at 16.15 EETGlaston has reviewed its strategy and updated its financial targets for the strategy period 2018–2021 as a result of its acquisition of Bystronic glass. The foundation of the strategy remains unchanged; we continue to seek growth in our core business and to win in services through digitalization. Combining the strengths of Bystronic glass and Glaston as well as leveraging the know-how Bystronic glass adds to our business, provides us with unique opportunities to build a strong machinery and services offering

Exel Composites Plc: Managers' Transactions – Kytömäki, Riku

EXEL COMPOSITES PLC        MANAGERS’ TRANSACTIONS     6 MAY 2019 at 16:15 EETPerson subject to the notification requirementName: Kytömäki, RikuPosition: Chief Executive OfficerIssuer: Exel Composites OyjLEI: 743700205JAMGM80QD88 Notification type: INITIAL NOTIFICATIONReference number: 743700205JAMGM80QD88_20190506152846_2 ____________________________________________ Transaction date: 2019-05-06Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI0009007306Nature of the transaction: ACQUISITION Transaction details(1): Volume: 2,400 Unit price: 4.23

Calliditas Therapeutics to host conference call to provide Business Update and 2019 Q1 report

On May 8, 2019, at 07:00am CET, Calliditas Therapeutics (“Calliditas”) will publish its business update for the first quarter 2019. The company will also host a telephone conference, which will include a presentation of the results, on the same day at 3:00pm CET. The event will be hosted by the company’s CEO and President, Renée Aguiar-Lucander, and CFO Fredrik Johansson. The presentation will be held in English. The presentation will be live on the company’s website during the call under Financial Reports and Presentations and will also be made available online after the call. To

Senzime signs Nordic distribution agreement with Vingmed Holding A/S

Press release: Uppsala, May 6, 2019. Senzime AB (publ) today announces that it has signed an exclusive distribution agreement with Vingmed Holding A/S for the commercialization of TetraGraph in Sweden, Denmark, Norway and Finland. The Vingmed Group consists of 4 direct sales organisations: Vingmed AS (Norway), Vingmed AB (Sweden), Vingmed ViCare A/S (Denmark), Vingmed Oy (Finland) and is one of the largest companies in the Nordic countries for distribution and services of high quality medical technical products. Anesthesia is one of their focus areas and high level of innovation

There are no items matching the current filter
There are no more items matching the current filter
Back to top